FDA Approves Belimumab for Patients Aged 5 With Systemic Lupus Erythematosus

Retrieved on: 2024-05-20 20:07:17

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves Belimumab for Patients Aged 5 With Systemic Lupus Erythematosus. View article details on hiswai:

Excerpt

Belimumab (Benlysta; GSK) is a B-lymphocyte stimulator-specific inhibiting monoclonal antibody.

Article found on: www.pharmacytimes.com